A purified inactivated Japanese encephalitis virus vaccine made in vero cells

Vaccine

Volumn 19, Issue 31, 2001, Pages 4557-4565

  Srivastava, Ashok K ^a   Putnak, J Robert ^a   Lee, Sung H ^b   Hong, Sun P ^b   Moon, Sang B ^b   Barvir, David A ^a   Zhao, Bangti ^a   Olson, Russell A ^a   Kim, Soo Ok ^b   Yoo, Wang Don ^b   Towle, Andrew C ^c   Vaughn, David W ^a   Innis, Bruce L ^a   Eckels, Kenneth H ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b CJ Corporation   (South Korea)

^c CJ America   (United States)

Author keywords

JE PIV; Vaccine; Vero cells

Indexed keywords

ALUMINUM HYDROXIDE; CELL PROTEIN; FORMALDEHYDE; GUANOSINE PHOSPHATE; INACTIVATED VACCINE; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; NUCLEIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG FORMULATION; FEMALE; HOST CELL; IMMUNOGENICITY; INFECTION PREVENTION; INOCULATION; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION; VERO CELL; VIRUS ENCEPHALITIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CERCOPITHECUS AETHIOPS; CYCLIC GMP; DRUG EVALUATION, PRECLINICAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; JAPANESE ENCEPHALITIS VACCINES; MICE; MICE, INBRED ICR; SERIAL PASSAGE; VACCINES, INACTIVATED; VERO CELLS; VIRUS REPLICATION;

EID: 0035860006     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00208-0     Document Type: Article

References (30)

1. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA
2. Flavivirus genome organization, expression and replication
3. Antigenicity of Japanese encephalitis virus envelope glycoprotein V3(E) and its cyanogen bromide cleaved fragments examined by monoclonal antibodies and Western blotting
4. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes
5. The epidemiology of Japanese encephalitis virus: Prospects for prevention
6. Japanese encephalitis vaccines
7. Japanese encephalitis
8. The natural history of Japanese encephalitis virus
9. Flaviviruses
10. Japanese encephalitis purified vaccine
11. Protection against Japanese encephalitis by inactivated vaccine
12. Allergic mucocutaneous reactions to Japanese encephalitis vaccine
13. Case-control study of allergic reactions to Japanese encephalitis vaccine
14. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine
15. Selection of better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis. I. Some biological characteristics of SA14-14-2 mutant
16. Safety of live attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children
17. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): A case-control study
18. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2 adapted to primary canine kidney cell cultures and preparation of a vaccine for human use
19. Polio and rabies vaccines produced in continuous cell lines: A reality for vero cell line
20. Rabies virus for human use, cultivated on Vero cell
21. The large-scale cultivation of Vero cells in microcarrier for virus vaccine production. Preliminary results for killed poliovirus vaccine
22. Development of a purified, inactivated, dengue-2 virus vaccine prototype in vero cells: Immunogenicity and protection in mice and rhesus monkeys
23. Study of SV40 by tissue culture. A preparatory stage for in vitro cancer researcher
24. Production and characterization of arbovirus antibody in mouse ascitic fluid
25. 'Western blotting': Electrophoretic transfer of proteins from sodium dodecyl sulphate polyacryalamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
26. Techniques for hemagglutination and hemagglutination-inhibition with arthropod borne viruses
27. Nucleotide sequence of virulent SA14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA14-14-2
28. The proteins of Japanese encephalitis
29. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines